查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855835

2025年全球云端基础罕见疾病家族登记市场报告

Cloud-Based Rare Disease Family Registry Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，云端基础的罕见疾病家族登记市场规模迅速扩张，从2024年的11.9亿美元成长到2025年的14亿美元，复合年增长率达17.8%。这一增长可归因于药物核准数量的增加、对医疗保健数数位化需求的增长、先进数据分析技术的日益普及、医疗机构自行录入（基于站点）的登记系统日益普及以及对真实世界证据（RWE）需求的不断增长。

预计未来几年，云端基础的罕见疾病家族登记市场将快速成长，到2029年市场规模将达到26.8亿美元，复合年增长率（CAGR）为17.6%。预测期内的成长主要受以下因素驱动：人工智慧主导的分析技术日益普及；製药公司越来越多地利用登记系统进行上市后监测；对模组化和专科特定登记系统的需求不断增长；透过入口网站和远端工具增强病人参与；以及健康资讯交换（HIE）和互通性标准的日益普及。预测期内的关键趋势包括：穿戴式装置和物联网装置的整合；用于安全资料共用的区块链解决方案的开发；远端医疗和远端监测的日益融合；交换医疗资讯（EHR）登记系统互通性的创新；标准化方面的投资；以及病患主导的资料收集的增加。

云端基础的罕见疾病家庭登记系统是一个线上平台，旨在安全地收集、储存和管理与罕见疾病相关的健康和家庭信息，使患者、家属和医疗保健专业人员能够远端共用数据，以支持研究、改善患者照护并促进临床试验招募。

云端基础的罕见疾病家族登记系统的关键组成部分是软体和服务。软体包含程式、资料和指令，使电脑或装置能够执行特定任务。部署选项包括公共云端、私有云端和混合云端解决方案。应用领域包括病患资料管理、研究、临床试验和基因资料收集。最终用户包括医院和诊所、研究机构、製药和生物技术公司、患者权益组织以及其他相关人员。

美国在2025年春季突然提高关税，由此引发的贸易摩擦对医疗保健产业造成了严重衝击，尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为了应对这项挑战，医疗产业正在积极调整筹资策略，尽可能地促进本地生产，并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供云端基础罕见疾病家族登记市场统计数据，包括全球市场规模、区域份额、市场份额主要竞争对手、云端基础的云端基础细分、市场趋势以及云端基础罕见疾病家族登记行业的商机。这份云端基础罕见疾病家族登记市场研究报告全面概​​述了您所需的一切信息，并对该行业的现状和未来发展趋势进行了深入分析。

精准医疗的日益普及预计将推动云端基础的罕见疾病家族登记市场成长。精准医疗根据个人的遗传、环境和生活方式因素量身定制治疗和预防策略。基因组序列测定技术的进步使得人们能够更准确地了解患者的基因组成，从而促进了精准医疗的应用。云端基础的罕见疾病家族登记系统透过集中管理包括基因、临床和治疗资讯在内的全面患者数据，为个人化医疗提供支持，从而帮助精准医疗的发展。例如，个人化医疗联盟在2024年2月报告称，美国食品药物管理局（FDA）在2023年核准了16种针对罕见疾病的新型个人化疗法。这些新治疗方法，包括针对癌症和其他疾病的疗法，都凸显了精准医疗日益受到重视。因此，这一趋势正在推动云端基础的罕见疾病家族登记市场的扩张。

在云端基础罕见疾病家族登记市场中营运的公司正在推出双语协作登记等创新倡议，以增强病患、家属和研究人员的参与度。双语协作登记是云端基础的系统，支援多种语言，并允许资料储存在本地站点，同时遵守当地的知情同意和隐私法规。例如，2025年6月，美国国家罕见疾病组织（NORD）宣布计画在加拿大推出两个病患登记系统：一个用于苯酮尿症（PKU），另一个用于黏多醣贮积症（MPS）。这些登记系统由NORD与加拿大倡议团体、临床医生和研究人员合作创建，将成为美国以外首批根据国际罕见疾病研究协会（IAMRARE）计画建立的登记系统。这些登记系统将遵守各州的知情同意法律，实现即时数据收集和分析，并支持罕见代谢疾病的研究、临床试验和患者招募。

2025年5月，总部位于美国的股权公司Vora Ventures收购了Hive Networks Inc.，旨在拓展其在罕见疾病和慢性病研究领域的影响力。 Hive Networks是一家医疗技术公司，提供云端基础的AI驱动平台，促进患者、家属、临床医生和研究人员之间的协作。此次收购旨在利用Hive Networks的平台作为安全资料交换的协作基础设施，从而改善罕见疾病和慢性病领域的研究合作、资料共用以及患者预后。

云端基础的罕见疾病家族登记市场由提供资料託管、资料整合、资料安全、资料共用、资料分析、资料储存、互通性支援、登记客製化、病人参与支援、技术支援、培训服务和维护服务等服务的实体所获得的收入所构成。市场价值包括服务供应商销售的任何营业单位商品的价值，或包含在其服务产品中的任何相关商品的价值。云端基础的罕见疾病家族登记市场还包括资料储存设备、网路设备、诊断试剂套件、生物辨识设备、病患监测设备、资料备份系统、安全硬体、运算工作站和行动装置的销售。该市场的价值为“出厂价”，即商品製造商或创造者销售的商​​品价值，无论销售对像是其他营业单位（包括下游製造商、批发商、经销商和零售商）还是直接销售给最终客户。该市场中的商品价值还包括商品创造者销售的任何相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球云端基础罕见疾病家族登记系统：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球云端基础罕见疾病家族登记市场：成长率分析
  • 全球云端基础罕见疾病家族登记市场表现：规模与成长，2019-2024年
  • 全球云端基础罕见疾病家族登记市场预测：规模与成长，2024-2029年，2034年预测
  • 全球云端基础的罕见疾病家族登记系统：潜在市场规模 (TAM)

第六章 市场细分

  • 全球云端基础罕见疾病家族登记市场：依组成部分划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 软体
  • 服务
  • 全球云端基础罕见疾病家族登记市场：依部署模式、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 公共云端
  • 私有云端
  • 混合云端
  • 全球云端基础罕见疾病家族登记市场：依应用领域划分，实际结果及预测（2019-2024年、2024-2029年预测、2034年预测）
  • 病患资料管理
  • 研究
  • 临床试验
  • 遗传资料收集
  • 其他用途
  • 全球云端基础的罕见疾病家族登记市场（依最终用户划分）、实际数据及预测（2019-2024年、2024-2029年预测、2034年预测）
  • 医院和诊所
  • 研究所
  • 製药和生物技术公司
  • 患者权益倡导组织
  • 其他最终用户
  • 全球云端基础罕见疾病家族登记市场：依软体、类型、实际值及预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 电子资料撷取
  • 资料管理平台
  • 分析和报告工具
  • 病人参与工具
  • 临床试验管理系统
  • 全球云端基础罕见疾病家族登记市场：依服务、类型、实际值及预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 实施与集成
  • 培训和支持
  • 资料託管与安全
  • 咨询服务
  • 维护和升级

第七章 区域和国家分析

  • 全球云端基础罕见疾病家族登记市场：依地区划分，实际结果及预测，2019-2024年、2024-2029年预测、2034年预测
  • 全球云端基础罕见疾病家族登记市场：按国家/地区划分，实际结果和预测，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 云端基础的罕见疾病家族登记市场：竞争格局
  • 云端基础的罕见疾病家族登记市场：公司概况
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • ICON plc Overview, Products and Services, Strategy and Financial Analysis
    • Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Parexel International Corp. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Medidata Solutions Inc.
  • FIGMD Inc.
  • OM1 Inc.
  • Mission Health Labs Inc.
  • TREAT-NMD Global Registries Platform
  • Seqster PDM Inc.
  • ArborMetrix Inc.
  • OpenClinica LLC
  • Pulse Infoframe Inc.
  • Oracle Healthcare Pvt. Ltd.
  • QuesGen Systems Inc.
  • FTD Disorders Registry
  • Castor LLC
  • Data Registry Services LLC
  • Fibrolamellar Registry

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年云端基础罕见疾病家族登记市场：提供新机会的国家
  • 2029年云端基础罕见疾病家族登记市场：提供新机会的细分市场
  • 2029年云端基础罕见疾病家族登记市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38484

A cloud-based rare disease family registry is an online platform designed to securely collect, store, and manage health and family information related to rare diseases. It enables patients, families, and healthcare professionals to share data remotely, supporting research, improving patient care, and facilitating clinical trial recruitment.

The primary components of a cloud-based rare disease family registry include software and services. Software consists of programs, data, and instructions that guide a computer or device in performing specific tasks. Deployment options include public cloud, private cloud, and hybrid cloud solutions. Applications include patient data management, research, clinical trials, genetic data collection, and others. End users include hospitals and clinics, research institutions, pharmaceutical and biotechnology companies, patient advocacy groups, and other stakeholders.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The cloud-based rare disease family registry market research report is one of a series of new reports from The Business Research Company that provides cloud-based rare disease family registry market statistics, including the cloud-based rare disease family registry industry global market size, regional shares, competitors with the cloud-based rare disease family registry market share, detailed cloud-based rare disease family registry market segments, market trends, and opportunities, and any further data you may need to thrive in the cloud-based rare disease family registry industry. This cloud-based rare disease family registry market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cloud-based rare disease family registry market size has grown rapidly in recent years. It will grow from $1.19 billion in 2024 to $1.40 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth observed during the historic period can be linked to the rising number of drug approvals, increasing demand for healthcare digitization, greater use of advanced data analytics, expanding adoption of provider-entered (site-based) registries, and growing demand for real-world evidence (RWE).

The cloud-based rare disease family registry market size is expected to see rapid growth in the next few years. It will grow to $2.68 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth projected for the forecast period can be attributed to increased integration of AI-driven analytics, greater use of registries by pharmaceutical companies for post-marketing surveillance, rising demand for modular and specialty-specific registries, enhanced patient engagement through portals and remote tools, and growing adoption of health information exchange (HIE) and interoperability standards. Key trends during the forecast period include integration of wearables and IoT devices, development of blockchain solutions for secure data sharing, advancement of telehealth and remote monitoring integration, innovation in EHR-registry interoperability, investment in standardization, and expansion of patient-driven data collection.

The growing emphasis on precision medicine is expected to accelerate the growth of the cloud-based rare disease family registry market. Precision medicine tailors medical treatment and prevention strategies based on an individual's genetic, environmental, and lifestyle factors. Advances in genomic sequencing have enabled more accurate insights into patients' genetic makeup, driving the adoption of precision medicine. Cloud-based rare disease family registries contribute to this by centralizing comprehensive patient data, including genetic, clinical, and treatment information, which supports personalized healthcare. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, a significant increase from the six approvals in 2022. These new therapies include treatments for cancer and other conditions, highlighting the growing focus on precision medicine. As a result, this trend is fueling the expansion of the cloud-based rare disease family registry market.

Companies operating in the cloud-based rare disease family registry market are introducing technological innovations, such as bilingual federated registries, to enhance patient, family, and researcher engagement. Bilingual federated registries are cloud-based systems that allow data to remain at local sites while supporting multiple languages and adhering to regional consent and privacy regulations. For example, in June 2025, the National Organization for Rare Disorders (NORD) announced plans to launch two Canadian patient registries for PKU and MPS. These registries, created in collaboration with Canadian advocacy groups, clinicians, and researchers, will be the first outside the U.S. in the IAMRARE Program. They will comply with provincial consent laws, enable real-time data collection and analysis, and support research into rare metabolic disorders, clinical trials, and patient recruitment.

In May 2025, Vora Ventures, a US-based equity firm, acquired Hive Networks Inc. to extend its reach in the rare and chronic disease research space. Hive Networks, a healthcare technology company, provides a cloud-based AI-powered platform for collaboration among patients, families, clinicians, and researchers. This acquisition is aimed at improving collaboration, data sharing, and patient outcomes in the rare and chronic disease sectors by leveraging Hive Networks' platform as a collaborative infrastructure for secure data exchange.

Major players in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central.

North America was the largest region in the cloud-based rare disease family registry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in cloud-based rare disease family registry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cloud-based rare disease family registry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cloud-based rare disease family registry market consists of revenues earned by entities by providing services such as data hosting, data integration, data security, data sharing, data analytics, data storage, interoperability support, registry customization, patient engagement support, technical support, and training services, maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cloud-based rare disease family registry market also includes sales of data storage devices, networking equipment, diagnostic kits, biometric devices, patient monitoring devices, data backup systems, security hardware, computing workstations, and mobile devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cloud-Based Rare Disease Family Registry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cloud-based rare disease family registry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cloud-based rare disease family registry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cloud-based rare disease family registry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Software; Services
  • 2) By Deployment Mode: Public Cloud; Private Cloud; Hybrid Cloud
  • 3) By Application: Patient Data Management; Research; Clinical Trials; Genetic Data Collection; Other Applications
  • 4) By End-User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Patient Advocacy Groups; Other End-Users
  • Subsegments:
  • 1) By Software: Electronic Data Capture; Data Management Platform; Analytics And Reporting Tools; Patient Engagement Tools; Clinical Trial Management System
  • 2) By Services: Implementation And Integration; Training And Support; Data Hosting And Security; Consulting Services; Maintenance And Upgrades
  • Companies Mentioned: Thermo Fisher Scientific Inc.; IQVIA Holdings Inc.; ICON plc; Syneos Health Inc.; Parexel International Corp.; Medidata Solutions Inc.; FIGMD Inc.; OM1 Inc.; Mission Health Labs Inc.; TREAT-NMD Global Registries Platform; Seqster PDM Inc.; ArborMetrix Inc.; OpenClinica LLC; Pulse Infoframe Inc.; Oracle Healthcare Pvt. Ltd.; QuesGen Systems Inc.; FTD Disorders Registry; Castor LLC; Data Registry Services LLC; Fibrolamellar Registry; Rare Central
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cloud-Based Rare Disease Family Registry Market Characteristics

3. Cloud-Based Rare Disease Family Registry Market Trends And Strategies

4. Cloud-Based Rare Disease Family Registry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cloud-Based Rare Disease Family Registry Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Cloud-Based Rare Disease Family Registry PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Cloud-Based Rare Disease Family Registry Market Growth Rate Analysis
  • 5.4. Global Cloud-Based Rare Disease Family Registry Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Cloud-Based Rare Disease Family Registry Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Cloud-Based Rare Disease Family Registry Total Addressable Market (TAM)

6. Cloud-Based Rare Disease Family Registry Market Segmentation

  • 6.1. Global Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Services
  • 6.2. Global Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Public Cloud
  • Private Cloud
  • Hybrid Cloud
  • 6.3. Global Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Data Management
  • Research
  • Clinical Trials
  • Genetic Data Collection
  • Other Applications
  • 6.4. Global Cloud-Based Rare Disease Family Registry Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Patient Advocacy Groups
  • Other End-Users
  • 6.5. Global Cloud-Based Rare Disease Family Registry Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic Data Capture
  • Data Management Platform
  • Analytics And Reporting Tools
  • Patient Engagement Tools
  • Clinical Trial Management System
  • 6.6. Global Cloud-Based Rare Disease Family Registry Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implementation And Integration
  • Training And Support
  • Data Hosting And Security
  • Consulting Services
  • Maintenance And Upgrades

7. Cloud-Based Rare Disease Family Registry Market Regional And Country Analysis

  • 7.1. Global Cloud-Based Rare Disease Family Registry Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Cloud-Based Rare Disease Family Registry Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cloud-Based Rare Disease Family Registry Market

  • 8.1. Asia-Pacific Cloud-Based Rare Disease Family Registry Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cloud-Based Rare Disease Family Registry Market

  • 9.1. China Cloud-Based Rare Disease Family Registry Market Overview
  • 9.2. China Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cloud-Based Rare Disease Family Registry Market

  • 10.1. India Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cloud-Based Rare Disease Family Registry Market

  • 11.1. Japan Cloud-Based Rare Disease Family Registry Market Overview
  • 11.2. Japan Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cloud-Based Rare Disease Family Registry Market

  • 12.1. Australia Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cloud-Based Rare Disease Family Registry Market

  • 13.1. Indonesia Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cloud-Based Rare Disease Family Registry Market

  • 14.1. South Korea Cloud-Based Rare Disease Family Registry Market Overview
  • 14.2. South Korea Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cloud-Based Rare Disease Family Registry Market

  • 15.1. Western Europe Cloud-Based Rare Disease Family Registry Market Overview
  • 15.2. Western Europe Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cloud-Based Rare Disease Family Registry Market

  • 16.1. UK Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cloud-Based Rare Disease Family Registry Market

  • 17.1. Germany Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cloud-Based Rare Disease Family Registry Market

  • 18.1. France Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cloud-Based Rare Disease Family Registry Market

  • 19.1. Italy Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cloud-Based Rare Disease Family Registry Market

  • 20.1. Spain Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cloud-Based Rare Disease Family Registry Market

  • 21.1. Eastern Europe Cloud-Based Rare Disease Family Registry Market Overview
  • 21.2. Eastern Europe Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cloud-Based Rare Disease Family Registry Market

  • 22.1. Russia Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cloud-Based Rare Disease Family Registry Market

  • 23.1. North America Cloud-Based Rare Disease Family Registry Market Overview
  • 23.2. North America Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cloud-Based Rare Disease Family Registry Market

  • 24.1. USA Cloud-Based Rare Disease Family Registry Market Overview
  • 24.2. USA Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cloud-Based Rare Disease Family Registry Market

  • 25.1. Canada Cloud-Based Rare Disease Family Registry Market Overview
  • 25.2. Canada Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cloud-Based Rare Disease Family Registry Market

  • 26.1. South America Cloud-Based Rare Disease Family Registry Market Overview
  • 26.2. South America Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cloud-Based Rare Disease Family Registry Market

  • 27.1. Brazil Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cloud-Based Rare Disease Family Registry Market

  • 28.1. Middle East Cloud-Based Rare Disease Family Registry Market Overview
  • 28.2. Middle East Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cloud-Based Rare Disease Family Registry Market

  • 29.1. Africa Cloud-Based Rare Disease Family Registry Market Overview
  • 29.2. Africa Cloud-Based Rare Disease Family Registry Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Cloud-Based Rare Disease Family Registry Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Cloud-Based Rare Disease Family Registry Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cloud-Based Rare Disease Family Registry Market Competitive Landscape And Company Profiles

  • 30.1. Cloud-Based Rare Disease Family Registry Market Competitive Landscape
  • 30.2. Cloud-Based Rare Disease Family Registry Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. ICON plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Syneos Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Parexel International Corp. Overview, Products and Services, Strategy and Financial Analysis

31. Cloud-Based Rare Disease Family Registry Market Other Major And Innovative Companies

  • 31.1. Medidata Solutions Inc.
  • 31.2. FIGMD Inc.
  • 31.3. OM1 Inc.
  • 31.4. Mission Health Labs Inc.
  • 31.5. TREAT-NMD Global Registries Platform
  • 31.6. Seqster PDM Inc.
  • 31.7. ArborMetrix Inc.
  • 31.8. OpenClinica LLC
  • 31.9. Pulse Infoframe Inc.
  • 31.10. Oracle Healthcare Pvt. Ltd.
  • 31.11. QuesGen Systems Inc.
  • 31.12. FTD Disorders Registry
  • 31.13. Castor LLC
  • 31.14. Data Registry Services LLC
  • 31.15. Fibrolamellar Registry

32. Global Cloud-Based Rare Disease Family Registry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cloud-Based Rare Disease Family Registry Market

34. Recent Developments In The Cloud-Based Rare Disease Family Registry Market

35. Cloud-Based Rare Disease Family Registry Market High Potential Countries, Segments and Strategies

  • 35.1 Cloud-Based Rare Disease Family Registry Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Cloud-Based Rare Disease Family Registry Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Cloud-Based Rare Disease Family Registry Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer